H. Haybar, S. Shahrabi, Hadi Rezaeeyan
Feb 15, 2019
Citations
1
Influential Citations
30
Citations
Quality indicators
Journal
Journal of Cellular Physiology
Abstract
Arsenic trioxide (ATO) is a drug commonly used for the treatment of acute promyelocytic leukemia (APL). Although ATO has been shown to cause significant improvement in patients, it is associated with serious side effects, which sometimes lead to the patient's death. In this review paper, we examine the reports of ATO‐induced cardiotoxicity in APL patients and evaluate the strategies to reduce the incidence of such toxicity.